From her GLP-1 weight loss journey to her new partnership with Ro, Serena Williams has sparked months of debate. Here's why her transformation remains so controversial.

Blockbuster weight-loss drugs are being linked to a rare but upsetting side effect that’s showing up in the shower drain. As ...

The battle between drugs used for diabetes and weight loss could be headed to court over tv advertisements.

GLP-1 medications may be new, but the belief that smaller bodies hold the answer is not. What can two centuries of ...

Novo Nordisk filed a lawsuit against Eli Lilly that alleges advertising falsely claims Wegovy is weaker than it is.

The lawsuit alleges that Eli Lilly misled consumers by using outdated clinical trial data to make its drugs appear more ...

Novo Nordisk sues Eli Lilly over GLP-1 weight-loss drug ads comparing Zepbound vs Wegovy doses; see what’s alleged, why it ...

Novo asked the court to permanently stop Lilly from running the "deceptive" ads and require the drugmaker to issue corrective ...

Novo Nordisk has accused Eli Lilly of running ad campaigns containing “deliberately false” messages that mislead the public ...

Novo Nordisk sued rival drugmaker Eli Lilly, alleging false advertising claims about relative weight-loss drug performance.